Initially developed as a treatment for Oguchi disease [27], which occurs in individuals with rod opsin and GRK1 mutations that prevent phosphorylation, these arrestin mutants have their ‘phosphorylation sensor’ removed, increasing their affinity for photoactivated unphosphorylated opsin. The gene discussed is GRK1; the disease is Oguchi disease.